Cardiovascular risk and prevention are central themes in public health initiatives and individual healthcare strategies, given the significant impact of cardiovascular diseases on global morbidity and mortality. Cardiovascular risk factors encompass a range of conditions and behaviors that increase the likelihood of developing heart-related problems. Common risk factors include hypertension, hyperlipidemia, diabetes, smoking, sedentary lifestyle, and poor dietary habits. Identifying and managing these risk factors are critical steps in preventing cardiovascular diseases. Healthcare professionals employ risk assessment tools to estimate an individual's likelihood of experiencing a cardiovascular event over a specified period. Prevention strategies involve lifestyle modifications, including adopting a heart-healthy diet, engaging in regular physical activity, smoking cessation, and managing underlying health conditions. Additionally, pharmacological interventions such as statins or antihypertensive medications may be prescribed when necessary to control specific risk factors.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States